Quantcast

Posts related to ‘ACAD’

BioHealth Business Daily (ACAD, AEN, DNDN, EXAS, ITMN, MIPI, OREX, OSIP, RNN, SLXP, VVUS)

We are seeing many news-related movers in today's edition of the BioHealth Business Daily.  ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), Adeona Pharmaceuticals, Inc. (AMEX: AEN), Dendreon Corporation (NASDAQ: DNDN), Exact Sciences ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ACAD, ACE, AACC, RATE, GYMB, KIM, MMC, MVL, NCR, WSH)

These aren't all of the analyst calls out there today, but these are ten of the calls impacting shares early this Tuesday morning:ACADIA Pharmaceuticals (ACAD) Raised to Neutral at Banc ...
Read Full Story »

The 52-Week Low Club (PPC)(PBG)(RCL)(GHS)(ACAD)

Pilgrim's Pride (PPC) Downgraded by Credit Suisse. Down to $15.67 from 52-week high of $41.Pepsi Bottling Group (PBG) Still troubled by problems at one of Coke's bottlers. Down to $29.22 ...
Read Full Story »

Biotech Busine$$ Daily (ACAD, AMLN, CVTX, HALO, KOSN, MCU, NVAX, POZN, REGN, SIRT)

If you thought biotech news was getting quiet going into earnings season, think again.Acadia Pharmaceuticals Inc. (ACAD) presents Phase II data on pimavanserin, a treatment  for Parkinson’s disease psychosis (PDP) ...
Read Full Story »

Pre-Market Analyst Calls (July 10, 2007)

ACAD started as Outperform at FBR.ALC started as Outperform at RBC.ARUN started as Buy at Jefferies.ATVI started as Buy at First Albany.AZ raised to Buy at UBS.CHA cut to Hold ...
Read Full Story »

Cramer Speculates in CV Therapeutics (CVTX)

On tonight's Mad Money on CNBC, Jim Cramer had his normal 'Speculation Friday' and talked CV Therapeutics (CVTX) for a speculative biotech in with Acadia (ACAD) and Nastech (NSTK).  Cramer ...
Read Full Story »

Pre-Market Stock News (June 6, 2007)

(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded up over 10% after Jim Cramer touted the stock as ...
Read Full Story »

Cramer Backs Acadia Pharmaceuticals (ACAD)

Cramer has a speculative little drug stock that keeps getting thrown to him in the Lightning Round: Acadia Pharmaceuticals (ACAD).  Cramer thinks now is the time that you can buy ...
Read Full Story »